Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Axsome Therapeutics (AXSM) Debt Ratio (2022 - 2025)

Historic Debt Ratio for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to 0.28.

  • Axsome Therapeutics' Debt Ratio fell 1632.53% to 0.28 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28, marking a year-over-year decrease of 1632.53%. This contributed to the annual value of 0.33 for FY2024, which is 600.61% up from last year.
  • Axsome Therapeutics' Debt Ratio amounted to 0.28 in Q3 2025, which was down 1632.53% from 0.29 recorded in Q2 2025.
  • Axsome Therapeutics' 5-year Debt Ratio high stood at 0.56 for Q1 2022, and its period low was 0.28 during Q3 2025.
  • For the 4-year period, Axsome Therapeutics' Debt Ratio averaged around 0.35, with its median value being 0.32 (2025).
  • As far as peak fluctuations go, Axsome Therapeutics' Debt Ratio tumbled by 4560.8% in 2023, and later soared by 1352.08% in 2024.
  • Axsome Therapeutics' Debt Ratio (Quarter) stood at 0.3 in 2022, then grew by 3.79% to 0.31 in 2023, then increased by 6.01% to 0.33 in 2024, then dropped by 15.66% to 0.28 in 2025.
  • Its Debt Ratio stands at 0.28 for Q3 2025, versus 0.29 for Q2 2025 and 0.32 for Q1 2025.